Orion Corporation is a globally operating Finnish pharmaceutical
company – a builder of well-being. Orion develops, manufactures and
markets human and veterinary pharmaceuticals and active pharmaceutical
ingredients.
Description of position
In the CNS Therapy Area, we are building up our portfolio and are
looking for enthusiastic and innovative scientists who can contribute in
the field of neurodegenerative disorders (NDD) or chronic pain in our
laboratory in Turku, Finland.
Your main responsibilities will be to:
Establish, characterize and implement state-of-the-art cellular
models to unravel disease mechanisms in neurodegenerative diseases (PD
& ALS) and pain
Setup new in-vitro technologies and protocols
Build-up in-vitro target validation and help translate to in-vivo assays
Generate and evaluate new project ideas with other pain/ neurodegenerative diseases (NDD) scientists
Actively contribute to project ideation, planning and execution of research activities in the fields of NDD and/or pain
Analyse and interpret data and effectively conclude, document and communicate results
Interface with external academic, biotechnology, and contract research organizations
Collaborate with other CNS scientists & groups & global functions within the company
Description of unit
Therapy area of the Central Nervous System (CNS) is accountable for
the research and development of medications for NDD and pain at Orion.
Our team builds the R&D CNS portfolio and CNS strategy in close
collaboration with business and all R&D global functions. We are
focusing on Parkinson’s disease (PD), Amyotrophic lateral sclerosis
(ALS) and chronic pain. Currently, we are about 20 people working for
the CNS portfolio, including a laboratory team for the Disease Biology
ensuring that we get data from well-planned and conducted experiments to
verify target confidence and to ensure the way forward for the new
ideas and research projects. This position belongs to the Disease
Biology team in Turku, Finland, which we is growing to meet our future
needs.
We offer
We offer exciting opportunities to create and have an impact to the future therapies for patients.
In Orion we have a highly interesting R&D pipeline and
enthusiastic working environment with opportunities to use your own
strengths to build your competence development and career. As an expert
of your own field you will be a member of multi-disciplinary team
jointly innovating and developing new treatments for the patients.
Appreciation of colleagues and continuous development are part of our
core values. The culture of Orion R&D is informal and we enjoy
working together.
We are passionate about the patient welfare and serve as The Voice of
Science and the Patient – if this inspires you too – join us!
We wish you have:
PhD in Neuroscience, cell biology or other related field (0+ year(s) experience; Title will depend on experience)
Industry experience is an advantage
Strong expertise in cell culture, including primary neurons and iPSC
Technical skills in biochemical, molecular and cell biology
techniques, gene editing and viral vector technologies, and microscopy
and imaging are desirable
Good networking and communication skills and willingness to
collaborate with Internal & External partners (academic and
industrial)
Good organizational and people skills and working in a team environment
Passion to work in the laboratory
Fluent written and spoken English
Additional information
Would you like to know more about the position? Please contact Malik
John Mohammed, Research Director NDD +358509667871. He is best available
during the following times (EEST): Friday 25th of Oct 9.00 –
11.00, Thursday 31st of Oct 15.00 – 16.00 and Friday 8th of Nov 15.00 –
16.00.
Orion Corporation operates in more than 25 countries, where we
Orionees, 3400 in total, work in all kinds of positions. We encourage
people to develop their competences, and offer opportunities to affect
own job description and create own career path at Orion.
#LI-ORION
Approved medical examination
which also includes drug testing is required prior to the employment. We
will also carry out a security clearance prior to the employment for
the selected person.
Orion Corporation is a globally operating Finnish pharmaceutical
company – a builder of well-being. Orion develops, manufactures and
markets human and veterinary pharmaceuticals and active pharmaceutical
ingredients.
Job description
We are looking for a professional with a strong background in
delivery technologies especially for large molecules for CNS and
oncology targets to establish technology platform for these technologies
in Turku, Finland. In order to drive successfully our internal drug
discovery programs your primary responsibilities will include designing,
planning, executing and troubleshooting of lipid based delivery
vehicles including physico-chemical characterization, stability studies,
PK and PD studies. Together with Biologics function other option like
bispecific antibodies fusion proteins and aptamers are on the scope as
well. You contribute actively to development of analytical methods for
thorough characterization of delivery vehicles. Much of the progress is
done in the laboratory and you will therefore have a good possibility to
do a lot of hands-on laboratory work. As a senior scientist, evaluation
and supporting discovery collaborations and CRO activities on you
competence area is a part of your job description.
Description of the unit
Orion’s pharmaceutical innovations are created within its R&D
organization, including e.g. non-clinical research, clinical
development, formulation development and medical affairs. The
organization employs top professionals in the field of drug molecule
development and optimization.
The newly established Biologics and New Modalities team is part of
our R&D organization and it is responsible for bringing as new
treatment modalities for Orion’s pipeline covering therapeutic
nucleotides, delivery technologies and gene therapy. Adding the
possibility to modulate the target with either small or large molecules
enables us to choose the right target and then use the best modalities
to modulate the target protein in order to create the best value for
patients. To fulfill this exciting task the New Modalities function is
strengthened by recruiting new R&D experts with a track record of on
advanced therapy modalities. The function is currently to set up and
you have a great opportunity to be part of developing our processes.
We offer
We offer exciting opportunities to create and have an impact to the future therapies for patients.
In Orion we have a highly interesting R&D pipeline and
enthusiastic working environment with opportunities to use your own
strengths to build your competence development and career. As an expert
of your own field you will be a member of multi-disciplinary team
jointly innovating and developing new treatments for the patients.
Appreciation of colleagues and continuous development are part of our
core values. The culture of Orion R&D is informal and we enjoy
working together.
We are passionate about the patient welfare and serve as The Voice of
Science and the Patient – if this inspires you too – join us!
Requirements
To succeed in this senior scientist role you should have a PhD in
biology, pharmacy or biophysics with a track record of developing drug
delivery vehicles and thorough hands-on experience of laboratory work
and several years of working experience from pharma industry in
developing novel solutions for large drug molecule delivery for CNS
indications. You have thorough working knowledge and understanding of
nanoparticle or liposomal delivery formulations.
Since you have a central role in implementing these new delivery
technologies to our portfolio patience and willingness to create new
things is a must. The role includes collaboration within Orion and with
various collaborators therefore strong communication skills and an
ability to convince your audience is an asset.
Contact information
Would you like to know more about the position? Please contact Jyrki
Lehtimäki, Senior Manager Strategic Development, +358509667478. He is
best available during the following times (Finnish times): 1st November
at 14-15 pm and 6th November at 9-10 am or 15-16 pm. Please send us your
application by November 17th.
Orion Corporation operates in more than 25 countries, where we
Orionees, 3200 in total, work in all kinds of positions. We encourage
people to develop their competences, and offer opportunities to affect
own job description and create own career path at Orion.
Orion Corporation is a globally operating Finnish pharmaceutical company
– a builder of well-being. Orion develops, manufactures and markets
human and veterinary pharmaceuticals and active pharmaceutical
ingredients.
Description of position
In this Research
assistant role your days will include hands-on laboratory work such as
pharmacological testing, biophysical characterization and preparation of
therapeutic antibodies and nucleotides (incl. binding and functional
studies), cell culture, assay set-ups and validations. You will
schedule, execute and report the experiments. You will also provide
assistance to the team when larger studies are conducted.
Description of the unit
Orion’s pharmaceutical innovations are created within its R&D
organization, including e.g. non-clinical research, clinical
development, formulation development and medical affairs. The
organization employs top professionals in the field of drug molecule
development and optimization.
The recently established
Biologics and New Modalities teams are part of our R&D organization
and they are responsible for bringing forward our increasing or
biologics and new modalities pipeline in the therapy areas Oncology, CNS
and Rare diseases. Adding the possibility to modulate the target with
either small or large molecules enables us to choose the right target
and then use the best modalities to affect the target protein in order
to create the best value for patients. To fulfill this exciting task
these teams are now recruiting additional R&D experts with a track
record of developing biopharmaceuticals. These teams have recently been
established and you have a great opportunity to be part of developing
our processes.
We offer
We offer exciting opportunities to create and have an impact to the future therapies for patients.
In Orion we have a highly interesting R&D pipeline and enthusiastic
working environment with opportunities to use your own strengths to
build your competence development and career. As an expert of your own
field you will be a member of multi-disciplinary team jointly innovating
and developing new treatments for the patients. Appreciation of
colleagues and continuous development are part of our core values. The
culture of Orion R&D is informal and we enjoy working together.
We are passionate about the patient welfare and serve as The Voice of
Science and the Patient – if this inspires you too – join us!
Requirements
To be successful in this role we hope you have hands-on experience of
laboratory work related to antibody or nucleotide engineering and
background of cell biology, immunology or biochemistry. Laboratory
working experience in pharma industry is an advantage and experience in
laboratory work using viral vectors is also considered beneficial.
Additionally we expect that you have a BSc degree in a related field
(for example biotechnology engineering or health sciences).
In
our team, it is important that you are not afraid to take
responsibilities and you enjoy helping others. You are accurate and
persistent in your work. Good communication skills in English are needed
and you work well with others. We hope you are excited of getting new
tasks and developing yourself.
Contact information
Would you like to know more about the position? Please contact Tim
Holmström, Head of Biologics, +358509667314. He is best available during
the following times (EEST): Monday 4th of November between 9-10 AM, and
Wednesday 13th of November between 9-10 AM.
Orion Corporation
operates in more than 25 countries, where we Orionees, 3200 in total,
work in all kinds of positions. We encourage people to develop their
competences, and offer opportunities to affect own job description and
create own career path at Orion.
#LI-ORION
WWW-osoite http://www.orion.fi Yhteystiedot
Would you like to know more about the position? Please contact Tim
Holmström, Head of Biologics, +358509667314. He is best available during
the following times (EEST): Monday 4th of November between 9-10 AM, and
Wednesday 13th of November between 9-10 AM. Työpaikan osoite 20380 TURKU Työ alkaa Mahdollisimman pian Työaika kokoaikatyö Työn kesto yli 12 kuukautta Haku päättyy 17.11.2019 Ilmoitus jätetty 29.10.2019 Ilmoitusnumero 10149266
Our international multidisciplinary research group (https://bioscience.fi/research/molecular-systems-immunology/profile/ ) led by Academy Professor Riitta Lahesmaa is based at Turku Centre for Biotechnology (the Centre), BioCity Turku, Turku, Finland. We are seeking for a motivated a postdoctoral researcher or a project researcher with possibility to continue work as a doctoral candidate.
Disorders in immune system and lymphocyte function lead to inflammatory diseases e.g. rheumatoid arthritis and Type 1 Diabetes. Project will focus on studying the molecular mechanisms underlying immune mediated diseases aiming at enabling individualized treatment in the future.
Description of our organization Molecular Systems Immunology group aims at understanding the regulation of human immune system to predict, prevent and treat immune mediated disorders. We study epigenetic and transcriptional regulation of T cells and molecular mechanisms of immune mediated diseases such as Type 1 Diabetes.
Turku Bioscience Centre is a joint research institute of University of Turku and Åbo Akademi University. The mission of the Centre is to promote high quality research and training. The Centre has excellent state-of-the-art technology platforms and expertise in single-cell omics, NGS, epigenomics, proteomics, computational biology and high-end cell imaging.
Qualifications
Successful candidates have:
A relevant doctor’s degree (senior/postdoctoral researcher) or a relevant master’s degree (project researcher) e.g. in life sciences or in biomedicine
High level of motivation, self-initiative and independency
Excellent team work and communication skills in English (both oral and written)
First-rate molecular and cell biology knowledge and skills with a strong background in epigenetics.
Strong publication record in international journals (postdoctoral researcher) at least in one of the following areas: immunology, molecular and cellular biology, autoimmunity, genetics, epigenetics.
Application The salary is determined by the collective agreement system of Finnish universities. These positions belong to our research personnel and the salary for a postdoctoral researcher will be 2600 – 3600 eur/month in average (or 3100 – 4200 eur/month depending on experience) and for a project researcher 2150 – 2600 eur/month in average.The position starts at earliest on Jan 1st, 2019 (or as agreed). The positions are initially for two years, one optional year possible. There is a trial period of six months.
Please include a CV, full publication list, list of selected publications and contact information for three references in your application. In addition postdoctoral researcher applicants should also enclose academic portfolio (https://www.utu.fi/en/university/come-work-with-us/academic-portfolio)
For further information on please contact: Prof. Riitta Lahesmaa, e-mail: riitta.lahesmaa (at)utu.fi .
Enquiries on the application procedure may be directed to HR Specialist Paula Luoma paula.luoma(at)utu.fi
Marie Skłodowska-Curie Actions (MSCA) Innovative Training Network (ITN)
CANCERPREV
Innovative strategies for cancer prevention with focus on sex hormone signaling and chronic inflammation
Overview
Incidence and prevalence of many cancer types are substantially increasing worldwide[1] for three main reasons:
increased life span and aging populations,
improved methods of early detection, and
increased survival of cancer patients.
Changes in known and unknown environmental factors modify the
age-specific incidences of cancers. However, more sophisticated and
expensive treatments cannot be afforded by all societies, increasing the
urgency of boosting efforts in cancer prevention. This can be realized in three ways:
primary cancer prevention, aimed at reducing
overall cancer incidence at the population level, assessing the impact
of life style, occupational/environmental hazards, and genetic risk
factors in parallel with large-scale screening and vaccination efforts;
secondary cancer prevention,
aimed at early detection of premalignant and confined malignant
lesions, and identification of high risk lesions for removal and/or
suppression;
tertiary cancer prevention, aimed at preventing cancer recurrence in patients after treatment of a primary cancer.
This Innovative Training Network aims to establish an interdisciplinary PhD program in cancer prevention focused on two key determinants of cancer risk:
sex hormone signaling and
chronic inflammation.
Both can be significantly affected by exogenous factors such as
endocrine disruptors, cigarette smoke, and sunlight, as well as
intrinsic changes occurring with aging. Genetic influences on cancer
risk, as they relate specifically to endocrine and inflammation
signaling pathways, will be considered by analysis of a unique resource
of identical and dizygotic twin cohorts. In addition, novel
chemoprevention approaches will be assessed using chemically-developed
hormone and inflammation inhibitors. Finally, mechanistic studies will
exploit innovative preclinical mouse models developed by the
participating labs.
Through early stage researcher (ESR) co-supervision, interactive meetings and workshops, we will develop an effective cancer prevention strategy of major societal impact together with non-academic partners for: (i) novel biomarker identification and drug development; (ii) science communication efforts and public outreach.
ITN Participating Laboratories and Research Projects
This training network is based on the unifying guiding
hypothesis that sex hormone action (Work Package 1) and chronic
inflammation (Work Package 2) are important determinants of increased
cancer risk in aging populations, and that insights in these fields can
be used for novel translational applications (Work Package 3). As illustrated in the figure, we
will focus on breast and skin cancer as benchmarks of major clinical
significance, in organs with reproductive and non-reproductive
functions, respectively. The enrolled PhD students (ESRs) will address
the links between sex hormone signaling, persistent chronic
inflammation, and genetic and behavioral/environmental cancer risk
factors. They will devote most of their time and efforts to develop an
in depth research project in one of the main participating laboratories
under the direct supervion of one of the Principla Investigators (PIs).
However, they are expected to further develop and carry out some of
their research work in one or more of the other participating
laboratories, under the joint supervision of other PIs. On top of
rigorous research training, an essential objective of the program is for
students to develop scientific communication and outreach skills, which
may lead to new career opportunities in academia or the private
sector.
Summary of CANCERPREV research topics and interactions. CANCERPREV
studies breast and skin cancer as benchmarks of cancer development in
organs with reproductive or non-reproductive functions (B). The unifying
hypothesis is that deregulation of sex hormone signaling (WP1) and
inflammation (WP2) play key roles in susceptibility and premalignant to
malignant conversion of both tumor types, and that insights can be
exploited clinically (WP3).
Participating laboratories and available research projects
The CancerPrev selection committee, composed of the participating
PIs, will review and rank all applications and candidates passing the
first round of selection will be invited for an oral interview, either
by Skype or in person. At that time, they will be asked by the
interviewers to prepare a short written document on a paper / topic of
relevance to their projected future work.
Starting dates are flexible, earliest date is March 1st 2019.
Terveyden ja hyvinvoinnin laitos (THL) on asiantuntija- ja tutkimuslaitos. Tuotamme tietoa, työkaluja ja ratkaisuja terveys- ja hyvinvointialan päätöksenteon ja toiminnan tueksi. Vahvuuksiamme ovat merkityksellinen työ, osaava ja intohimoisesti työhönsä suhtautuva henkilöstö ja loistavat tietovarannot. Teemme kansainvälisesti ja kansallisesti arvokasta tutkimusta ja sovellamme sitä suomalaisen yhteiskunnan tulevaisuuden rakentamiseen. THL:ssä työskentelee noin 1100 asiantuntijaa ja tutkijaa. THL on savuton työpaikka.
Viran/tehtävän kuvaus
Terveyden ja hyvinvoinnin laitoksen valtion palvelut osaston oikeustoksikologian yksikkö hakee kliinisen kemian laboratoriotoimintoihin tutkimuspäällikköä tai erikoistutkijaa vakinaiseen työsuhteeseen.
Tutkimuspäällikön tai erikoistutkijan tehtävänä on kehittää ja johtaa kliinisen kemian akkreditoituja laboratoriotoimintoja sekä tutkimusprojekteja. Tutkimuspäällikkö tai erikoistutkija toimii alansa asiantuntijana kansantautien suoja- ja riskitekijöitä (esim. diabetes, sydän- ja verisuonitaudit) selvittävissä tutkimuksissa. Tarjoamme monipuolisia tehtäviä monitieteellisissä kotimaisissa ja kansainvälisissä yhteistyöprojekteissa sekä hyvässä laboratoriotyöyhteisössä.
Turvallisuusselvitys
Virkaan tai tehtävään valittavasta henkilöstä voidaan tehdä hakijan suostumuksella henkilöturvallisuusselvitys (Turvallisuusselvityslaki 726/2014). Turvallisuusselvitysmenettelystä ja selvityksen kohteen oikeuksista löytyy tarkempia tietoja osoitteessa www.supo.fi.
Hakijalta odotamme
Odotamme hakijalta soveltuvaa ylempää korkeakoulututkintoa, sekä teoreettista ja käytännön osaamista kliinisen kemian analytiikasta. Edellytämme hakijalta tutkimusten ja laboratoriotyön suunnittelun ja kehittämisen osaamista ja kokonaisuuksien hahmottamista sekä hyviä vuorovaikutustaitoja. Aikaisempi kokemus akkreditoidussa laboratoriossa työskentelystä sekä soveltuva tohtorin tutkinto ja tutkimustausta katsotaan eduksi. Eduksi katsotaan myös hyvä kielitaito (suomi, ruotsi, englanti) viestintään ja kansainvälisten kontaktien hoitamiseen ja julkaisemiseen.
Palkkaukseen liittyvät tiedot
Tehtävä sijoittuu THL:n palkkausjärjestelmän vaativuustasoihin 4-5, jossa peruspalkka on 3598,50 tai 4044,70 euroa/kk. Lisäksi maksetaan suoriutumiseen perustuvaa henkilökohtaista palkanosaa maksimissaan 50 %.
Muut tehtävään liittyvät tiedot
Tehtävässä on 6 kk koeaika.
Tehtävän kesto Vakinainen
Alkamisaika 1.11.2019 tai sopimuksen mukaan.
Työaikamuoto Virastotyöaika
Työpaikkojen lukumäärä 1
Sijainti
Terveyden ja hyvinvoinnin laitos Mannerheimintie 166 00300 Helsinki
AH diagnostics jälleenmyy innovatiivisia tuotteita molekyylibiologiseen ja immunologiseen tutkimukseen, sekä diagnostiikan tarpeisiin. Kaikilla tuotespesialisteillamme on olennainen biotieteellinen koulutus. Osaamisalueisiimme kuuluu huolto, alan tuntemus ja ammattimainen tuki asiakkaillemme. Tämän varmistamme tuotespesialistiemme ja huoltoteknikoittemme jatkuvalla koulutuksella, sekä lisäpätevyyksiä hankkimalla. Visiomme on olla ensisijainen toimittaja innovatiivisille laatutuotteille, laitteille sekä tuelle tutkimuksessa, diagnostiikassa ja laboratoriovälineissä kaikissa pohjoismaissa. AH diagnostics perustettiin 1986 ja sen pääkonttori on Århusissa. Tänä päivänä meillä on 50 työntekijää ympäri pohjoismaita.
Product Specialist – Molekyylibiologia
Etsimme innokasta ja energistä molekyylibiologian asiantuntijaa vastaamaan AH diagnosticsin molekyylibiologian tuotevalikoiman myynnistä ja markkinoinnista. Valikoimamme sisältää markkinoiden uusimpia menetelmiä ja innovatiivisia tuotteita mm. näillä osa-alueilla: NGS, CRISPR, kloonaus, Western Blotting, PCR, DNA-RNA eristys.
Tehtävääsi kuuluu AH diagnosticsin tuotevalikoiman myynti ja tuki Suomessa, asiakassuhteiden luominen ja ylläpito, sekä erilaisten markkinointitoimenpiteiden (seminaarit, näyttelyt ym.) suunnittelu ja koordinointi. Apunasi tehtävässä ovat pohjoismaiset applikaatiopäälliköt sekä ammattitaitoinen markkinointitiimi. Osana AH diagnosticsin tiimiä pääset kehittämään omaa tietotaitoasi alan uusimpien teknologioiden parissa. Pääset myös tutustumaan asiakkaidemme tutkimukseen läheltä ja suuri osa työstä onkin asiakkaiden parissa tehtävää myyntiä. Product Specialistina sinulla on akateeminen tutkinto sekä taustaa molekyylibiologian tuotteiden parista ja hyvät tiedot NGS, PCR, QPCR, kloonaus, WB sekä mahdollisesti muista molekyylibiologian menetelmistä. Kommunikoit sujuvasti suomeksi ja englanniksi. Sinulla on tietotaitoa ja kiinnostusta työskennellä sekä laitteiden että kulutustavaroiden parissa. Olet itsenäinen, hyvin organisoitu ja sinulla on erinomaiset kommunikaatio- ja ongelmanratkaisutaidot. Sinulla on mahdollisesti jo aiempaa myyntikokemusta. Product Specialistina toimit läheisessä yhteystyössä asiakkaiden kanssa ja työsi edellyttää matkustamista Suomessa ja ajokorttia.
Tarjoamme erittäin mielenkiintoisen tehtävän, jossa pääset tutustumaan uusimpiin molekyylibiologian teknologioihin sekä kehittymään Product Specialistina erittäin mukavien asiakkaiden ja mielenkiintoisten tuotteiden parissa. Panostamme työntekijöidemme jatkuvaan koulutukseen ja työhyvinvointiin. Suomen tiimin tuki ja hyvä henki auttavat sinua tavoitteiden saavuttamisessa.
Lähetä hakemuksesi alla olevan linkin kautta, liitä mukaan englannin kielinen CV:si ja palkkatoiveesi viimeistään 27.10.2019 mennessä. Ole ripeä, käynnistämme haastattelut jo hakuajan kuluessa.
Tehtävä sijaitsee Turun yliopiston biolääketieteen laitoksessa, professori Pentikäisen johtamassa hankkeessa.
Tehtävä on määräaikainen ajalle 11.11.2019 – 10.11.2020. Tehtävän aloitusajankohta voidaan sopia myös toisin.
Erikoistutkijan tehtävään otettavalta edellytetään tohtorin tutkintoa ja kykyä itsenäiseen tieteelliseen työhön. Opetus- ja tutkimushenkilöstön tehtävärakenteen kolmannelle portaalle sijoittavissa tehtävissä edellytetään lisäksi näyttöä tieteellisestä tutkimustyöstä sekä tehtävässä tarvittavaa opetustaitoa.
Tehtävässä noudatetaan kuuden (6) kuukauden koeaikaa.
Tehtävän menestyksellinen hoitaminen edellyttää osaamista ja aiempaa työkokemusta tietokoneavusteisessa lääkeainesuunnittelussa, erityisesti proteiinin rakenteeseen perustuvien virtuaaliseulontamenetelmien käytöstä ja niissä löydettyjen molekyylien optimoinnista johtolankamolekyyleiksi. Tehtävään valittavalla tulee olla hyvät sosiaaliset taidot ja sujuva englanninkielen taito.
Turun yliopiston biolääketieteen laitos ja ympäröivä moderni tutkimusinfrastruktuuri yhdessä tarjoavat erinomaiset olosuhteet tämän projektin suorittamiseen.
Erikoistutkijan tehtäväkohtainen palkkaus määräytyy yliopistojen palkkausjärjestelmän opetus- ja tutkimushenkilöstön mukaisesti tehtäväkohtaisen palkanosan ollessa 2935,55 – 3423,25 euroa kuukaudessa (vaativuustasot 5-6). Lisäksi maksetaan henkilökohtaiseen suoriutumiseen perustuvaa palkanosaa 6-50 % tehtäväkohtaisesta palkasta.
Hakemukset tulee jättää viimeistään tiistaina 22.10.2019 (klo 23:59) yliopiston sähköisellä hakulomakkeella. Hakemukseen tulee liittää enintään yhden sivun mittainen englanninkielinen motivaatiokirje ja cv. Suosittelijoita, jotka ovat antaneet luvan, että käytät heitä suosittelijoina, pyydetään nimeämään kolme (3).
Jess, huomenna on seminaaripäivä! Vaikka Korpin ilmoittautuminen on jo sulkeutunut, niin mukaan pääsee vielä ilmoittautumalla sähköpostiin suomensolubiologit@gmail.com! Kaikki mukaan!
Suomen Solubiologit ry:n työelämäseminaari järjestetään tiistaina 12.11.2019 Jyväskylän yliopiston Ambiotica-salissa, ja mukana on jälleen erinomainen puhujakattaus kertomassa erilaisista solu- ja molekyylibiologian alan uravalinnoista. Tule kuulemaan minkälaisiin töihin alan opiskelija voi päätyä, seminaarissamme pääset tutustumaan puhujiin helposti ja luomaan kontakteja! Seminaari huipentuu Suomen Solubiologit ry:n gradupalkinnon jakamiseen, minkä jälkeen jatketaan rentoa keskustelua ja yhdessäoloa perinteisesti viinin ja snacksien lomassa. Lisäksi arvomme kaikkien osallistujien kesken Matti Vuennon uutuuskirjan, Bakteerien planeetta!
Mikäli olet Jyväskylän yliopiston opiskelija, ilmoittaudu seminaariin korpissa! Muussa tapauksessa ilmoittaudu mukaan laittamalla sähköpostia osoitteeseen suomensolubiologit@gmail.com
The Kuopio Center for Gene and Cell Therapy (KCT) is a research institute focused on developing novel gene and cell therapy products in the class known as advanced therapy medicinal products (ATMPs). KCT’s niche is in the interface between academic research and the commercial biotechnology industry. In addition to Cell Therapy expertise KCT has extensive experience dealing with the design, development and manufacturing of AAV, adenovirus and lentivirus vectors.
The Gene Therapy Unit at KCT invites applications for a Research Scientist position. We are seeking a creative investigator, who is able to both plan and take forward selected research projects. The projects may involve, but are not limited to adenovirus vector’s virus-host interactions, vector manufacturing development, lentivirus vector modifications, producer cell line modifications and analytical assay development.
Successful candidates will have a degree (MSc/PhD) in biosciences, virology, microbiology, biochemistry, molecular biology, cell biology or related fields. Expertise in cell culture, transfections, virus production, transductions, virus titering assays, analytical assay qualification/validation, assay statistics, ELISAs, ddPCR, electron microscopy, automated image analysis or flow cytometry can be highly beneficial.
We hope that your way of working is systematic and precise. As a person, we would like you to be open-minded towards new challenges and spread good team spirit. You also need to communicate fluently both in written and spoken English and have good computer skills.
The position is 2-year fixed term. We offer you active and lively work community with highly skilled and experienced personnel in translational research.
WWW-osoite http://www.kct.fi Yhteystiedot Vesa Turkki, vesa.turkki@kct.fi Työpaikan osoite Microkatu 1, 70210 KUOPIO Työ alkaa sopimuksen mukaan Työaika kokoaikatyö Työn kesto yli 12 kuukautta Haku päättyy 10.11.2019 Ilmoitus jätetty 09.10.2019 Ilmoitusnumero 10128329
